Pharmaceutical

mRNA licensing agreements double with million-dollar deals

mRNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in precision medicine.

Oct 8, 2024 - 04:00
mRNA licensing agreements double with million-dollar deals
mRNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in precision medicine.
Read the original article

Tags:

Previous Article

NUHS’s CD7 CAR-T cell therapy shows promise for leukaemia

Next Article

Editas Sells Rights to a Licensing Agreement in a $57 Million Deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The FDA isn’t afraid to yank a disappointing drug

The FDA isn’t afraid to yank a disappointing drug

Feb 27, 2024

STAT+: Stump Pharmalot: An Ask Me Anything with Ed Silverman

STAT+: Stump Pharmalot: An Ask Me Anything with Ed Silv...

Feb 23, 2024

STAT+: Pharmalittle: GSK manufacturing workers in the U.K. to strike in May; weight-loss drugs prompt strange dreams

STAT+: Pharmalittle: GSK manufacturing workers in the U...

Apr 19, 2023